Novo Nordisk A/S
Novo Nordisk’s diabetes drug Ozempic may reduce the risk of Alzheimer’s disease, study says
Steve Christo – Corbis | Corbis News | Getty Images Novo Nordisk‘s blockbuster diabetes drug Ozempic may reduce the risk of developing Alzheimer’s disease, suggesting its potential to delay or prevent the memory-robbing condition, according to a study released Thursday. Semaglutide, the active ingredient in Ozempic, was associated with a 40% to 70% lower risk […]
Read More
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Yet another study […]
Read More
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters Novo Nordisk on Tuesday asked the Food and Drug Administration to prevent compounding pharmacies from making unapproved and often cheaper versions of its popular weight loss injection Wegovy and diabetes treatment Ozempic, arguing that the medications are […]
Read More
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good afternoon and happy […]
Read More
U.S. FDA to reconsider decision barring compounded versions of Lilly weight loss drug
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders from selling their own versions of Eli Lilly’s blockbuster weight loss and diabetes drugs. The agency said […]
Read More
Wegovy and Zepbound rival targeting ‘next generation’ of obesity drugs, Zealand Pharma CEO says
Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly. CEO Adam Steensberg told CNBC Thursday that early-stage trials of its experimental obesity injection point to higher-quality weight loss — with reduced muscle loss and fewer side effects — […]
Read More
Ozempic underworld: Inside the black market of obesity drugs
BOULDER, COLO. — Not far from the majestic Rocky Mountains is an ordinary suburban neighborhood, a tree-lined street and a modest light gray home. It’s not the kind of place you’d imagine an investigation into black market Ozempic would lead. But it did. A CNBC investigation into counterfeit weight loss drugs revealed an international illegal […]
Read More
Morgan Stanley’s Slimmon says the U.S. infrastructure sector is ‘very powerful,’ naming a stock to buy
Stocks in the infrastructure sector aren’t always top of mind. When it comes to investing, tech stocks like chipmaker Nvidia or Novo Nordisk in the weight loss space have been the headline-grabbers over the last year. But investors who want to diversify their portfolios away from those popular names and themes can consider the infrastructure […]
Read More
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound, caught up in East Coast trade shutdown
An Eli Lilly & Co. Zepbound injection pen, March 28, 2024. Bloomberg | Bloomberg | Getty Images As a port strike stretching from New England to Texas halted nearly half of all trade coming into the U.S., customs data shows that critical medical devices and drug components for the booming, expensive weight-loss and diabetes drugs […]
Read More
East and Gulf Coast ports strike, with ILA longshoremen walking off job from New England to Texas, stranding billions in trade
Shipping containers sit stacked in the Port of Newark on September 30, 2024 seen from New York City. A massive strike shutting down ports across the East and Gulf coasts began at midnight as members of the International Longshoremen’s Association continue to make salary and other demands to the United States Maritime Alliance, which controls […]
Read More